TFOS DEWS II Epidemiology Report

Ocular Surface

Volumn 15, Issue 3, 2017, Pages 334-365

  Stapleton, Fiona ^a   Alves, Monica ^b   Bunya, Vatinee Y ^c   Jalbert, Isabelle ^a   Lekhanont, Kaevalin ^d   Malet, Florence ^e   Na, Kyung Sun ^f   Schaumberg, Debra ^g,h   Uchino, Miki ⁱ   Vehof, Jelle ^j,k   Viso, Eloy ^l   Vitale, Susan ^m   Jones, Lyndon ⁿ  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d MAHIDOL UNIVERSITY   (Thailand)

^e HÔPITAL PELLEGRIN   (France)

^f The Catholic University of Korea   (South Korea)

^g HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^h UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

ⁱ KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j ST THOMAS HOSPITAL   (United Kingdom)

^k UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^l Galicia Sur Health Research Institute   (Spain)

^m NATIONAL EYE INSTITUTE   (United States)

ⁿ UNIVERSITY OF WATERLOO   (Canada)

more..

Author keywords

Dry eye disease; Incidence; Natural history; Prevalence; Quality of life; Questionnaire; Risk factor; Societal cost

Indexed keywords

AGE; ASIAN; DIABETES MELLITUS; DIET SUPPLEMENTATION; DRY EYE; DRY EYE EPIDEMIOLOGY PROJECT; DRY EYE QUESTIONNAIRE; ENVIRONMENTAL EXPOSURE; EYE DISEASE ASSESSMENT; GENETIC RISK; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERITABILITY; HISTORY; HUMAN; INCIDENCE; KNOWLEDGE; MCMONNIES DRY EYE QUESTIONNAIRE; MEIBOMIAN GLAND DYSFUNCTION; MENTAL HEALTH; MOOD DISORDER; MORBIDITY; NORTH CAROLINA DRY EYE MANAGEMENT SCALE; PREVALENCE; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; REFRACTIVE SURGERY; RETINOL DEFICIENCY; REVIEW; RISK FACTOR; SEX; SJOEGREN SYNDROME; SOMATOFORM DISORDER; STANDARD PATIENT EVALUATION OF EYE DRYNESS; SUBJECTIVE EVALUATION OF SYMPTOM OF DRYNESS; VISION; WOMEN'S HEALTH; WOMEN'S HEALTH STUDY QUESTIONNAIRE; CROSS-SECTIONAL STUDY; FEMALE; MALE; META ANALYSIS; QUESTIONNAIRE;

CROSS-SECTIONAL STUDIES; DRY EYE SYNDROMES; FEMALE; HUMANS; MALE; PREVALENCE; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES;

EID: 85025456987     PISSN: 15420124     EISSN: 19375913     Source Type: Journal    
DOI: 10.1016/j.jtos.2017.05.003     Document Type: Review

References (237)

1. The epidemiology of dry eye disease: report of the epidemiology subcommittee of the international dry eye WorkShop. Ocul Surf 2007:5 (2007), 93–107.
2. Viso, E., Gude, F., Rodríguez-Ares, M.T., The association of meibomian gland dysfunction and other common ocular diseases with dry eye: a population-based study in Spain. Cornea 30:1 (2011), 1–6.
3. Tong, L., Chaurasia, S.S., Mehta, J.S., Beuerman, R.W., Screening for meibomian gland disease: its relation to dry eye subtypes and symptoms in a tertiary referral clinic in Singapore. Invest Ophthalmol Vis Sci 51:7 (2010), 3449–3454.
4. Lemp, M.A., Crews, L.A., Bron, A.J., Foulks, G.N., Sullivan, B.D., Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study. Cornea 31:5 (2012), 472–478.
5. Galor, A., Feuer, W., Lee, D.J., Florez, H., Venincasa, V.D., Perez, V.L., Ocular surface parameters in older male veterans. Invest Ophthalmol Vis Sci 54:2 (2013), 1426–1433.
6. Schaumberg, D.A., Nichols, J.J., Papas, E.B., Tong, L., Uchino, M., Nichols, K.K., The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD. Invest Ophthalmol Vis Sci 52:4 (2011), 1994–2005.
7. Viso, E., Rodríguez-Ares, M.T., Abelenda, D., Oubiña, B., Gude, F., Prevalence of asymptomatic and symptomatic meibomian gland dysfunction in the general population of Spain. Invest Ophthalmol Vis Sci 53:6 (2012), 2601–2606.
8. Uchino, M., Schaumberg, D.A., Dogru, M., Uchino, Y., Fukagawa, K., Shimmura, S., et al. Prevalence of dry eye disease among Japanese visual display terminal users. Ophthalmology 115:11 (2008), 1982–1988.
9. Schaumberg, D.A., Dana, R., Buring, J.E., Sullivan, D.A., Prevalence of dry eye disease among US men: estimates from the Physicians’ Health Studies. Arch Ophthalmol 127:6 (2009), 763–768.
10. Uchino, M., Nishiwaki, Y., Michikawa, T., Shirakawa, K., Kuwahara, E., Yamada, M., et al. Prevalence and risk factors of dry eye disease in Japan: koumi study. Ophthalmology 118:12 (2011), 2361–2367.
11. Zhang, Y., Chen, H., Wu, X., Prevalence and risk factors associated with dry eye syndrome among senior high school students in a county of shandong province, China. Ophthalmic Epidemiol 19:4 (2012), 226–230.
12. Ahn, J.M., Lee, S.H., Rim, T.H., Park, R.J., Yang, H.S., Kim, T.I., et al., Epidemiologic Survey Committee of the Korean Ophthalmological Society. Prevalence of and risk factors associated with dry eye: the Korea national health and nutrition examination survey 2010-2011. Am J Ophthalmol 158:6 (2014), 1205–1214 e7.
13. Um, S.B., Kim, N.H., Lee, H.K., Song, J.S., Kim, H.C., Spatial epidemiology of dry eye disease: findings from South Korea. Int J Health Geogr, 13, 2014, 31.
14. Lu, P., Chen, X., Liu, X., Yu, L., Kang, Y., Xie, Q., et al. Dry eye syndrome in elderly Tibetans at high altitude: a population-based study in China. Cornea 27:5 (2008), 545–551.
15. Moss, S.E., Klein, R., Klein, B.E., Long-term incidence of dry eye in an older population. Optom Vis Sci 85:8 (2008), 668–674.
16. Jie, Y., Xu, L., Wu, Y.Y., Jonas, J.B., Prevalence of dry eye among adult Chinese in the Beijing Eye Study. Eye (Lond) 23:3 (2009), 688–693.
17. Tian, Y.J., Liu, Y., Zou, H.D., Jiang, Y.J., Liang, X.Q., Sheng, M.J., et al. Epidemiologic study of dry eye in populations equal or over 20 years old in Jiangning District of Shanghai. Zhonghua Yan Ke Za Zhi 45 (2009), 486–491.
18. Tong, L., Tongg, L., Saw, S.M., Lamoureux, E.L., Wang, J.J., Rosman, M., et al. A questionnaire-based assessment of symptoms associated with tear film dysfunction and lid margin disease in an Asian population. Ophthalmic Epidemiol 16:1 (2009 Jan-Feb), 31–37.
19. Guo, B., Lu, P., Chen, X., Zhang, W., Chen, R., Prevalence of dry eye disease in Mongolians at high altitude in China: the Henan eye study. Ophthalmic Epidemiol 17:4 (2010), 234–241.
20. Han, S.B., Hyon, J.Y., Woo, S.J., Lee, J.J., Kim, T.H., Kim, K.W., Prevalence of dry eye disease in an elderly Korean population. Arch Ophthalmol 129:5 (2011), 633–638.
21. Viso, E., Rodriguez-Ares, M.T., Gude, F., Prevalence of and associated factors for dry eye in a Spanish adult population (the Salnes Eye Study). Ophthalmic Epidemiol 16:1 (2009 Jan-Feb), 15–21.
22. Hashemi, H., Khabazkhoob, M., Kheirkhah, A., Emamian, M.H., Mehravaran, S., Shariati, M., et al. Prevalence of dry eye syndrome in an adult population. Clin Exp Ophthalmol 42:3 (2014), 242–248.
23. Malet, F., Le Goff, M., Colin, J., Schweitzer, C., Delyfer, M.N., Korobelnik, J.F., et al. Dry eye disease in French elderly subjects: the Alienor Study. Acta Ophthalmol 92:6 (2014), e429–e436.
24. Paulsen, A.J., Cruickshanks, K.J., Fischer, M.E., Huang, G.H., Klein, B.E., Klein, R., et al. Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life. Am J Ophthalmol 157:4 (2014), 799–806.
25. Vehof, J., Kozareva, D., Hysi, P.G., Hammond, C.J., Prevalence and risk factors of dry eye disease in a British female cohort. Br J Ophthalmol 98:12 (2014), 1712–1717.
26. Na, K.S., Han, K., Park, Y.G., Na, C., Joo, C.K., Depression, stress, quality of life, and dry eye disease in Korean women: a population-based study. Cornea 34:7 (2015), 733–738.
27. Tan, L.L., Morgan, P., Cai, Z.Q., Straughan, R.A., Prevalence of and risk factors for symptomatic dry eye disease in Singapore. Clin Exp Optomet 98:1 (2015), 45–53.
28. Uchino, M., Dogru, M., Yagi, Y., Goto, E., Tomita, M., Kon, T., et al. The features of dry eye disease in a Japanese elderly population. Optom Vis Sci 83:11 (2006), 797–802.
29. Siak, J.J., Tong, L., Wong, W.L., Cajucom-Uy, H., Rosman, M., Saw, S.M., et al. Prevalence and risk factors of meibomian gland dysfunction: the Singapore Malay eye study. Cornea 31:11 (2012), 1223–1228.
30. Uchino, M., Dogru, M., Uchino, Y., Fukagawa, K., Shimmura, S., Takebayashi, T., et al. Japan Ministry of Health study on prevalence of dry eye disease among Japanese high school students. Am J Ophthalmol 146:6 (2008), 925–929 e2.
31. Burckart, G.J., Figg, W.D., Brooks, M.M., Green, D.J., Troutman, S.M., Ferrell, R., et al. Multi-institutional study of outcomes after pediatric heart transplantation: candidate gene polymorphism analysis ofABCC2. J Pediatr Pharmacol Ther 19:1 (2014), 16–24.
32. Jeng, B.H., Holland, G.N., Lowder, C.Y., Deegan, W.F. 3rd, Raizman, M.B., Meisler, D.M., Anterior segment and external ocular disorders associated with human immunodeficiency virus disease. Surv Ophthalmol 52:4 (2007 Jul-Aug), 329–368.
33. Nichols, K.K., Mitchell, G.L., Zadnik, K., The repeatability of clinical measurements of dry eye. Cornea 23:3 (2004), 272–285.
34. Savini, G., Prabhawasat, P., Kojima, T., Grueterich, M., Espana, E., Goto, E., The challenge of dry eye diagnosis. Clin Ophthalmol 2:1 (2008), 31–55.
35. Lemp, M.A., Advances in understanding and managing dry eye disease. Am J Ophthalmol 146:3 (2008), 350–356.
36. Cho, P., Brown, B., Review of the tear break-up time and a closer look at the tear break-up time of Hong Kong Chinese. Optom Vis Sci 70:1 (1993), 30–38.
37. Ozdemir, M., Temizdemir, H., Age- and gender-related tear function changes in normal population. Eye (Lond) 24:1 (2010), 79–83.
38. Sullivan, B.D., Whitmer, D., Nichols, K.K., Tomlinson, A., Foulks, G.N., Geerling, G., et al. An objective approach to dry eye disease severity. Invest Ophthalmol Vis Sci 51:12 (2010), 6125–6130.
39. Sullivan, B.D., Crews, L.A., Messmer, E.M., Foulks, G.N., Nichols, K.K., Baenninger, P., et al. Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications. Acta Ophthalmol 92:2 (2014), 161–166.
40. Wolffsohn, J.S., Arita, R., Chalmers, R., Djalilian, A., Dogru, M., Dumbleton, K., et al. TFOS DEWS II Diagnostic Methodology report. Ocul Surf 15 (2017), 539–574.
41. Lekhanont, K., Rojanaporn, D., Chuck, R.S., Vongthongsri, A., Prevalence of dry eye in Bangkok, Thailand. Cornea 25:10 (2006), 1162–1167.
42. Bukhari, A., Ajlan, R., Alsaggaf, H., Prevalence of dry eye in the normal population in Jeddah, Saudi Arabia. Orbit 28:6 (2009), 392–397.
43. Yokoi, N., Komuro, A., Non-invasive methods of assessing the tear film. Exp Eye Res 78:3 (2004), 399–407.
44. Bartlett, J.D., Keith, M.S., Sudharshan, L., Snedecor, S.J., Associations between signs and symptoms of dry eye disease: a systematic review. Clin Ophthalmol 9 (2015), 1719–1730.
45. Baudouin, C., Aragona, P., Van Setten, G., Rolando, M., Irkeç M., Benítez del Castillo, J., et al., ODISSEY European Consensus Group members. Diagnosing the severity of dry eye: a clear and practical algorithm. Br J Ophthalmol 98:9 (2014), 1168–1176.
46. Hom, M.M., Martinson, J.R., Knapp, L.L., Paugh, J.R., Prevalence of Meibomian gland dysfunction. Optom Vis Sci 67:9 (1990), 710–712.
47. Schneider, A., Friedl, M.A., McIver, D.K., Woodcock, C.E., Mapping urban areas by fusing multiple sources of coarse resolution remotely sensed data. Photogram Eng Remote Sens 69:12 (2003), 1377–1386.
48. Geigy Scientific Table, Lentner, C., (eds.) Introduction to statistics, statistical tables, and mathematical formulae, eighth ed., 1982, CIBA-GEIGY Limited, Basle, Switzerland.
49. ®: a case study in collaboration. Stat Probab Lett 81:7 (2011), 842–851.
50. DerSimonian, R., Laird, N., Meta-analysis in clinical trials. Control Clin Trials 7:3 (1986), 177–188.
51. Schein, O.D., Tielsch, J.M., Munõz, B., Bandeen-Roche, K., West, S., Relation between signs and symptoms of dry eye in the elderly. A population-based perspective. Ophthalmology 104:9 (1997), 1395–1401.
52. McCarty, C.A., Bansal, A.K., Livingston, P.M., Stanislavsky, Y.L., Taylor, H.R., The epidemiology of dry eye in Melbourne, Australia. Ophthalmology 105:6 (1998), 1114–1119.
53. Schaumberg, D.A., Sullivan, D.A., Buring, J.E., Dana, M.R., Prevalence of dry eye syndrome among US women. Am J Ophthalmol 136:2 (2003), 318–326.
54. Moss, S.E., Klein, R., Klein, B.E., Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol 118:9 (2000), 1264–1268.
55. Lee, A.J., Lee, J., Saw, S.M., Gazzard, G., Koh, D., Widjaja, D., et al. Prevalence and risk factors associated with dry eye symptoms: a population based study in Indonesia. Br J Ophthalmol 86:12 (2002), 1347–1351.
56. Lin, P.Y., Tsai, S.Y., Cheng, C.Y., Liu, J.H., Chou, P., Hsu, W.M., Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study. Ophthalmology 110:6 (2003), 1096–1101.
57. Chia, E.M., Mitchell, P., Rochtchina, E., Lee, A.J., Maroun, R., Wang, J.J., Prevalence and associations of dry eye syndrome in an older population: the Blue Mountains Eye Study. Clin Exp Ophthalmol 31:3 (2003), 229–232.
58. Jacobs, R., Tran, U., Chen, H., Kassim, A., Engelhardt, B.G., Greer, J.P., et al. Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria. Bone Marrow Transplant 47:11 (2012), 1470–1473.
59. Ivanir, Y., Shimoni, A., Ezra-Nimni, O., Barequet, I.S., Prevalence of dry eye syndrome after allogeneic hematopoietic stem cell transplantation. Cornea 32:5 (2013), e97–101.
60. Uchino, M., Yokoi, N., Uchino, Y., Dogru, M., Kawashima, M., Komuro, A., et al. Prevalence of dry eye disease and its risk factors in visual display terminal users: the Osaka study. Am J Ophthalmol 156:4 (2013), 759–766.
61. Whitcher, J.P., Shiboski, C.H., Shiboski, S.C., Heidenreich, A.M., Kitagawa, K., Zhang, S., et al. A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjögren's Syndrome International Registry. Am J Ophthalmol 149:3 (2010), 405–415.
62. Liew, M.S., Zhang, M., Kim, E., Akpek, E.K., Prevalence and predictors of Sjogren's syndrome in a prospective cohort of patients with aqueous-deficient dry eye. Br J Ophthalmol 96:12 (2012), 1498–1503.
63. Vehof, J., Hysi, P.G., Hammond, C.J., A metabolome-wide study of dry eye disease reveals serum androgens as biomarkers. Ophthalmology 124 (2017), 505–511.
64. Sahai, A., Malik, P., Dry eye: prevalence and attributable risk factors in a hospital-based population. Indian J Ophthalmol 53:2 (2005), 87–91.
65. Nichols, J.J., Ziegler, C., Mitchell, G.L., Nichols, K.K., Self-reported dry eye disease across refractive modalities. Invest Ophthalmol Vis Sci 46:6 (2005), 1911–1914.
66. Galor, A., Feuer, W., Lee, D.J., Florez, H., Carter, D., Pouyeh, B., et al. Prevalence and risk factors of dry eye syndrome in a United States veterans affairs population. Am J Ophthalmol 152:3 (2011), 377–384 e2.
67. Onwubiko, S.N., Eze, B.I., Udeh, N.N., Arinze, O.C., Onwasigwe, E.N., Umeh, R.E., Dry eye disease: prevalence, distribution and determinants in a hospital-based population. Cont Lens Anterior Eye 37:3 (2014), 157–161.
68. Schein, O.D., Muñoz, B., Tielsch, J.M., Bandeen-Roche, K., West, S., Prevalence of dry eye among the elderly. Am J Ophthalmol 124:6 (1997), 723–728.
69. Kim, K.W., Han, S.B., Han, E.R., Woo, S.J., Lee, J.J., Yoon, J.C., et al. Association between depression and dry eye disease in an elderly population. Invest Ophthalmol Vis Sci 52:11 (2011), 7954–7958.
70. Galor, A., Feuer, W., Lee, D.J., Florez, H., Faler, A.L., Zann, K.L., et al. Depression, post-traumatic stress disorder, and dry eye syndrome: a study utilizing the national United States veterans affairs administrative database. Am J Ophthalmol 154:2 (2012), 340–346.
71. Basak, S.K., Pal, P.P., Basak, S., Bandyopadhyay, A., Choudhury, S., Sar, S., Prevalence of dry eye diseases in hospital-based population in West Bengal, Eastern India. J Indian Med Assoc 110:11 (2012), 789–794.
72. Li, J., Zheng, K., Deng, Z., Zheng, J., Ma, H., Sun, L., et al. Prevalence and risk factors of dry eye disease among a hospital-based population in southeast China. Eye Contact Lens 41:1 (2015), 44–50.
73. Pouyeh, B., Viteri, E., Feuer, W., Lee, D.J., Florez, H., Fabian, J.A., et al. Impact of ocular surface symptoms on quality of life in a United States veterans affairs population. Am J Ophthalmol 153:6 (2012), 1061–1066 e3.
74. The definition and classification of dry eye disease: report of the definition and classification subcommittee of the international dry eye WorkShop. Ocul Surf 2007:5 (2007), 75–92.
75. Nelson, J.D., Shimazaki, J., Benitez-del-Castillo, J.M., Craig, J.P., McCulley, J.P., Den, S., et al. The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci 52:4 (2011), 1930–1937.
76. Joffre, C., Souchier, M., Grégoire, S., Viau, S., Bretillon, L., Acar, N., et al. Differences in meibomian fatty acid composition in patients with meibomian gland dysfunction and aqueous-deficient dry eye. Br J Ophthalmol 92:1 (2008), 116–119.
77. Vieira, A.C., Mannis, M.J., Ocular rosacea: common and commonly missed. J Am Acad Dermatol 69:6 Suppl 1 (2013), S36–S41.
78. Borchman, D., Foulks, G.N., Yappert, M.C., Bell, J., Wells, E., Neravetla, S., et al. Human meibum lipid conformation and thermodynamic changes with meibomian-gland dysfunction. Invest Ophthalmol Vis Sci 52:6 (2011), 3805–3817.
79. Travo, A., Paya, C., Déléris, G., Colin, J., Mortemousque, B., Forfar, I., Potential of FTIR spectroscopy for analysis of tears for diagnosis purposes. Anal Bioanal Chem 406:9–10 (2014), 2367–2376.
80. Eom, Y., Lee, J.S., Kang, S.Y., Kim, H.M., Song, J.S., Correlation between quantitative measurements of tear film lipid layer thickness and meibomian gland loss in patients with obstructive meibomian gland dysfunction and normal controls. Am J Ophthalmol 155:6 (2013), 1104–1110.
81. Zeev, M.S., Miller, D.D., Latkany, R., Diagnosis of dry eye disease and emerging technologies. Clin Ophthalmol 8 (2014), 581–590.
82. Mathers, W.D., Lane, J.A., Sutphin, J.E., Zimmerman, M.B., Model for ocular tear film function. Cornea 15:2 (1996), 110–119.
83. Bergmann, M.T., Newman, B.L., Johnson, N.C. Jr., The effect of a diuretic (hydrochlorothiazide) on tear production in humans. Am J Ophthalmol 99:4 (1985), 473–475.
84. Mathers, W.D., Stovall, D., Lane, J.A., Zimmerman, M.B., Johnson, S., Menopause and tear function: the influence of prolactin and sex hormones on human tear production. Cornea 17:4 (1998), 353–358.
85. Akpek, E.K., Merchant, A., Pinar, V., Foster, C.S., Ocular rosacea: patient characteristics and follow-up. Ophthalmology 104:11 (1997), 1863–1867.
86. Donaldson, K.E., Karp, C.L., Dunbar, M.T., Evaluation and treatment of children with ocular rosacea. Cornea 26:1 (2007), 42–46.
87. Ghanem, V.C., Mehra, N., Wong, S., Mannis, M.J., The prevalence of ocular signs in acne rosacea: comparing patients from ophthalmology and dermatology clinics. Cornea 22:3 (2003), 230–233.
88. Arita, R., Morishige, N., Koh, S., Shirakawa, R., Kawashima, M., Sakimoto, T., et al. Increased tear fluid production as a compensatory response to meibomian gland loss: a multicenter cross-sectional study. Ophthalmology 122:5 (2015), 925–933.
89. Hu, Y., Matsumoto, Y., Dogru, M., Okada, N., Igarashi, A., Fukagawa, K., et al. The differences of tear function and ocular surface findings in patients with atopic keratoconjunctivitis and vernal keratoconjunctivitis. Allergy 62:8 (2007), 917–925.
90. Villani, E., Strologo, M.D., Pichi, F., Luccarelli, S.V., De Cilla, S., Serafino, M., et al. Dry eye in vernal keratoconjunctivitis: a cross-sectional comparative study. Medicine (Baltimore), 94, 2015, e1648.
91. Chen, L., Pi, L., Fang, J., Chen, X., Ke, N., Liu, Q., High incidence of dry eye in young children with allergic conjunctivitis in Southwest China. Acta Ophthalmol 94:8 (2016), e727–e730.
92. Dumbleton, K., Caffery, B., Dogru, M., Hickson-Curran, S., Kern, J., Kojima, T., et al., members of the TFOS International Workshop on Contact Lens Discomfort. The TFOS international workshop on contact lens discomfort: report of the subcommittee on epidemiology. Invest Ophthalmol Vis Sci 54:11 (2013), TFOS20–TFOS36.
93. Nichols, J.J., Willcox, M.D., Bron, A.J., Belmonte, C., Ciolino, J.B., Craig, J.P., et al. The TFOS international workshop on contact lens discomfort: executive summary. Invest Ophthalmol Vis Sci 54 (2013), TFOS7–TFOS13.
94. Stapleton, F., Stretton, S., Papas, E., Skotnitsky, C., Sweeney, D.F., Silicone hydrogel contact lenses and the ocular surface. Ocul Surf 4:1 (2006), 24–43.
95. Leite, S.C., de Castro, R.S., Alves, M., Cunha, D.A., Correa, M.E., da Silveira, L.A., et al. Risk factors and characteristics of ocular complications, and efficacy of autologous serum tears after haematopoietic progenitor cell transplantation. Bone Marrow Transplant 38:3 (2006), 223–227.
96. Ogawa, Y., Kuwana, M., Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation. Cornea 22:7 Suppl (2003), S19–S27.
97. Tabbara, K.F., Al-Ghamdi, A., Al-Mohareb, F., Ayas, M., Chaudhri, N., Al-Sharif, F., et al. Ocular findings after allogeneic hematopoietic stem cell transplantation. Ophthalmology 116:9 (2009), 1624–1629.
98. Uchino, M., Ogawa, Y., Uchino, Y., Mori, T., Okamoto, S., Tsubota, K., Comparison of stem cell sources in the severity of dry eye after allogeneic haematopoietic stem cell transplantation. Br J Ophthalmol 96:1 (2012), 34–37.
99. Wang, J.C., Teichman, J.C., Mustafa, M., O'Donnell, H., Broady, R., Yeung, S.N., Risk factors for the development of ocular graft-versus-host disease (GVHD) dry eye syndrome in patients with chronic GVHD. Br J Ophthalmol 99:11 (2015), 1514–1518.
100. Kamoi, M., Ogawa, Y., Uchino, M., Tatematsu, Y., Mori, T., Okamoto, S., et al. Donor-recipient gender difference affects severity of dry eye after hematopoietic stem cell transplantation. Eye (Lond) 25:7 (2011), 860–865.
101. Khan, R., Nair, S., Seth, T., Mishra, P., Mahapatra, M., Agarwal, T., et al. Ocular graft versus host disease in allogenic haematopoetic stem cell transplantation in a tertiary care centre in India. Indian J Med Res 142:5 (2015), 543–548.
102. Yang, W.J., Yang, Y.N., Cao, J., Man, Z.H., Yuan, J., Xiao, X., et al. Risk factors for dry eye syndrome: a retrospective case-control study. Optom Vis Sci 92:9 (2015), e199–e205.
103. Ogawa, Y., Kim, S.K., Dana, R., Clayton, J., Jain, S., Rosenblatt, M.I., et al. International chronic ocular graft-vs-host-disease (GVHD) consensus group: proposed diagnostic criteria for chronic GVHD (Part I). Sci Rep, 3, 2013, 3419.
104. Goto, E., Matsumoto, Y., Kamoi, M., Endo, K., Ishida, R., Dogru, M., et al. Tear evaporation rates in Sjögren syndrome and non-Sjögren dry eye patients. Am J Ophthalmol 144:1 (2007), 81–85.
105. Helmick, C.G., Felson, D.T., Lawrence, R.C., Gabriel, S., Hirsch, R., Kwoh, C.K., et al., National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 58:1 (2008), 15–25.
106. Pillemer, S.R., Matteson, E.L., Jacobsson, L.T., Martens, P.B., Melton, L.J. 3rd, O'Fallon, W.M., et al. Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County, Minnesota. Mayo Clin Proc 76:6 (2001), 593–599.
107. Akpek, E.K., Klimava, A., Thorne, J.E., Martin, D., Lekhanont, K., Ostrovsky, A., Evaluation of patients with dry eye for presence of underlying Sjögren syndrome. Cornea 28:5 (2009), 493–497.
108. Versura, P., Profazio, V., Cellini, M., Torreggiani, A., Caramazza, R., Eye discomfort and air pollution. Ophthalmologica 213:2 (1999), 103–109.
109. Gupta, N., Prasad, I., Himashree, G., D'Souza, P., Prevalence of dry eye at high altitude: a case controlled comparative study. High Alt Med Biol 9:4 (2008), 327–334.
110. Gupta, N., Prasad, I., Jain, R., D'Souza, P., Estimating the prevalence of dry eye among Indian patients attending a tertiary ophthalmology clinic. Ann Trop Med Parasitol 104:3 (2010), 247–255.
111. Novaes, P., Saldiva, P.H., Matsuda, M., Macchione, M., Rangel, M.P., Kara-José N., et al. The effects of chronic exposure to traffic derived air pollution on the ocular surface. Environ Res 110:4 (2010), 372–374.
112. Galor, A., Kumar, N., Feuer, W., Lee, D.J., Environmental factors affect the risk of dry eye syndrome in a United States veteran population. Ophthalmology 121:4 (2014), 972–973.
113. Hwang, S.H., Choi, Y.H., Paik, H.J., Wee, W.R., Kim, M.K., Kim, D.H., Potential importance of ozone in the association between outdoor air pollution and dry eye disease in South Korea. JAMA Ophthalmol, 2016, 10.1001/jamaophthalmol.2016.0139.
114. Cho, H.A., Cheon, J.J., Lee, J.S., Kim, S.Y., Chang, S.S., Prevalence of dry eye syndrome after a three-year exposure to a clean room. Ann Occup Environ Med, 26, 2014, 26.
115. Kaido, M., Kawashima, M., Yokoi, N., Fukui, M., Ichihashi, Y., Kato, H., et al. Advanced dry eye screening for visual display terminal workers using functional visual acuity measurement: the Moriguchi study. Br J Ophthalmol 99:11 (2015), 1488–1492.
116. Argilés, M., Cardona, G., Pérez-Cabré E., Rodríguez, M., Blink rate and incomplete blinks in six different controlled hard-copy and electronic reading conditions. Invest Ophthalmol Vis Sci 56:11 (2015), 6679–6685.
117. Wolkoff, P., Nøjgaard, J.K., Troiano, P., Piccoli, B., Eye complaints in the office environment: precorneal tear film integrity influenced by eye blinking efficiency. Occup Environ Med 62:1 (2005), 4–12.
118. Chu, C.A., Rosenfield, M., Portello, J.K., Blink patterns: reading from a computer screen versus hard copy. Optom Vis Sci 91:3 (2014), 297–302.
119. Marshall, S.J., Gorely, T., Biddle, S.J., A descriptive epidemiology of screen-based media use in youth: a review and critique. J Adolesc 29:3 (2006), 333–349.
120. Alves, M., Dias, A.C., Rocha, E.M., Dry eye in childhood: epidemiological and clinical aspects. Ocul Surf 6:1 (2008), 44–51.
121. Bhutta, Z.A., Chopra, M., Axelson, H., Berman, P., Boerma, T., Bryce, J., et al. Countdown to 2015 decade report (2000-10): taking stock of maternal, newborn, and child survival. Lancet 375:9730 (2010), 2032–2044.
122. Sherwin, J.C., Reacher, M.H., Dean, W.H., Ngondi, J., Epidemiology of vitamin A deficiency and xerophthalmia in at-risk populations. Trans R Soc Trop Med Hyg 106:4 (2012), 205–214.
123. Mayo-Wilson, E., Imdad, A., Herzer, K., Yakoob, M.Y., Bhutta, Z.A., Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: systematic review and meta-analysis. BMJ, 343, 2011, d5094.
124. Eckert, M.J., Perry, J.T., Sohn, V.Y., Boden, J., Martin, M.J., Rush, R.M., et al. Incidence of low vitamin A levels and ocular symptoms after Roux-en-Y gastric bypass. Surg Obes Relat Dis 6:6 (2010 Nov-Dec), 653–657.
125. Lee, W.B., Hamilton, S.M., Harris, J.P., Schwab, I.R., Ocular complications of hypovitaminosis a after bariatric surgery. Ophthalmology 112:6 (2005), 1031–1034.
126. Cooney, T.M., Johnson, C.S., Elner, V.M., Keratomalacia caused by psychiatric-induced dietary restrictions. Cornea 26:8 (2007), 995–997.
127. Duignan, E., Kenna, P., Watson, R., Fitzsimon, S., Brosnahan, D., Ophthalmic manifestations of vitamin A and D deficiency in two autistic teenagers: case reports and a review of the literature. Case Rep Ophthalmol 6:1 (2015 Jan-Apr), 24–29.
128. Hou, T.Y., McMurray, D.N., Chapkin, R.S., Omega-3 fatty acids, lipid rafts, and T cell signaling. Eur J Pharmacol 785 (2016), 2–9.
129. Marion-Letellier, R., Savoye, G., Ghosh, S., Polyunsaturated fatty acids and inflammation. IUBMB Life 67:9 (2015), 659–667.
130. Das, U.N., Essential Fatty acids - a review. Curr Pharm Biotechnol 7:6 (2006), 467–482.
131. Roncone, M., Bartlett, H., Eperjesi, F., Essential fatty acids for dry eye: a review. Cont Lens Anterior Eye 33 (2010), 49–54 quiz 100.
132. Rosenberg, E.S., Asbell, P.A., Essential fatty acids in the treatment of dry eye. Ocul Surf 8:1 (2010), 18–28.
133. Oleñik, A., Effectiveness and tolerability of dietary supplementation with a combination of omega-3 polyunsaturated fatty acids and antioxidants in the treatment of dry eye symptoms: results of a prospective study. Clin Ophthalmol 8 (2014), 169–176.
134. Bhargava, R., Kumar, P., Phogat, H., Kaur, A., Kumar, M., Oral omega-3 fatty acids treatment in computer vision syndrome related dry eye. Cont Lens Anterior Eye 38:3 (2015), 206–210.
135. Gatell-Tortajada, J., Oral supplementation with a nutraceutical formulation containing omega-3 fatty acids, vitamins, minerals, and antioxidants in a large series of patients with dry eye symptoms: results of a prospective study. Clin Interv Aging 11 (2016), 571–578.
136. Jones, L., Downie, L.E., Korb, D., Benitez-del-Castillo, J.M., Dana, R., Deng, S.X., et al. TFOS DEWS II Management and Therapy report. Ocul Surf 15 (2017), 575–629.
137. Hom, M.M., Asbell, P., Omegas, Barry B., Dry eye: more knowledge, more questions. Optom Vis Sci 92 (2015), 948–956.
138. Chao, C., Golebiowski, B., Stapleton, F., The role of corneal innervation in LASIK-induced neuropathic dry eye. Ocul Surf 12:1 (2014), 32–45.
139. Nettune, G.R., Pflugfelder, S.C., Post-LASIK tear dysfunction and dysesthesia. Ocul Surf 8:3 (2010), 135–145.
140. Konomi, K., Chen, L.L., Tarko, R.S., Scally, A., Schaumberg, D.A., Azar, D., et al. Preoperative characteristics and a potential mechanism of chronic dry eye after LASIK. Invest Ophthalmol Vis Sci 49:1 (2008), 168–174.
141. Albietz, J.M., Lenton, L.M., McLennan, S.G., Dry eye after LASIK: comparison of outcomes for Asian and Caucasian eyes. Clin Exp Optom 88:2 (2005), 89–96.
142. Huang, J.C., Sun, C.C., Chang, C.K., Ma, D.H., Lin, Y.F., Effect of hinge position on corneal sensation and dry eye parameters after femtosecond laser-assisted LASIK. J Refract Surg 28:9 (2012), 625–631.
143. Mian, S.I., Li, A.Y., Dutta, S., Musch, D.C., Shtein, R.M., Dry eyes and corneal sensation after laser in situ keratomileusis with femtosecond laser flap creation Effect of hinge position, hinge angle, and flap thickness. J Cataract Refract Surg 35:12 (2009), 2092–2098.
144. Tuisku, I.S., Lindbohm, N., Wilson, S.E., Tervo, T.M., Dry eye and corneal sensitivity after high myopic LASIK. J Refract Surg 23:4 (2007), 338–342.
145. Wang, T.J., Wang, I.J., Hu, C.C., Lin, H.C., Comorbidities of dry eye disease: a nationwide population-based study. Acta Ophthalmol 90:7 (2012), 663–668.
146. Manaviat, M.R., Rashidi, M., Afkhami-Ardekani, M., Shoja, M.R., Prevalence of dry eye syndrome and diabetic retinopathy in type 2 diabetic patients. BMC Ophthalmol, 8, 2008, 10.
147. Najafi, L., Malek, M., Valojerdi, A.E., Aghili, R., Khamseh, M.E., Fallah, A.E., et al. Dry eye and its correlation to diabetes microvascular complications in people with type 2 diabetes mellitus. J Diabetes Complications 27:5 (2013 Sep-Oct), 459–462.
148. Achtsidis, V., Eleftheriadou, I., Kozanidou, E., Voumvourakis, K.I., Stamboulis, E., Theodosiadis, P.G., et al. Dry eye syndrome in subjects with diabetes and association with neuropathy. Diabetes Care 37:10 (2014), e210–e211.
149. Akinci, A., Cetinkaya, E., Aycan, Z., Dry eye syndrome in diabetic children. Eur J Ophthalmol 17:6 (2007 Nov-Dec), 873–878.
150. Labbé A., Wang, Y.X., Jie, Y., Baudouin, C., Jonas, J.B., Xu, L., Dry eye disease, dry eye symptoms and depression: the Beijing Eye Study. Br J Ophthalmol 97:11 (2013), 1399–1403.
151. van der Vaart, R., Weaver, M.A., Lefebvre, C., Davis, R.M., The association between dry eye disease and depression and anxiety in a large population-based study. Am J Ophthalmol 159:3 (2015), 470–474.
152. Yang, H., Gu, J., Zhu, Q., Lu, H., Wang, K., Ni, X., et al. Protection of acute GVHD by all-trans retinoic acid through suppression of T cell expansion and induction of regulatory T cells through IL-2 signaling. Int Immunopharmacol 28:2 (2015), 911–916.
153. Vehof, J., Zavos, H.M., Lachance, G., Hammond, C.J., Williams, F.M., Shared genetic factors underlie chronic pain syndromes. Pain 155:8 (2014), 1562–1568.
154. Karaiskos, D., Mavragani, C.P., Makaroni, S., Zinzaras, E., Voulgarelis, M., Rabavilas, A., et al. Stress, coping strategies and social support in patients with primary Sjögren's syndrome prior to disease onset: a retrospective case-control study. Ann Rheum Dis 68:1 (2009), 40–46.
155. Galor, A., Zlotcavitch, L., Walter, S.D., Felix, E.R., Feuer, W., Martin, E.R., et al. Dry eye symptom severity and persistence are associated with symptoms of neuropathic pain. Br J Ophthalmol 99:5 (2015), 665–668.
156. Chen, C.H., Yang, T.Y., Lin, C.L., Chen, C.S., Lin, W.M., Kuo, C.N., et al. Dry eye syndrome risks in patients with fibromyalgia: a national retrospective cohort study. Medicine (Baltimore), 95, 2016, e2607.
157. Vehof, J., Wang, B., Kozareva, D., Hysi, P.G., Snieder, H., Hammond, C.J., The heritability of dry eye disease in a female twin cohort. Invest Ophthalmol Vis Sci 55:11 (2014), 7278–7283.
158. Chandra, A., Charteris, D., Molecular pathogenesis and management strategies of ectopia lentis. Eye (Lond) 28:2 (2014), 162–168.
159. Mackey, D.A., Hewitt, A.W., Genome-wide association study success in ophthalmology. Curr Opin Ophthalmol 25:5 (2014), 386–393.
160. Lessard, C.J., Li, H., Adrianto, I., Ice, J.A., Rasmussen, A., Grundahl, K.M., et al. Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome. Nat Genet 45:11 (2013), 1284–1292.
161. Li, Y., Zhang, K., Chen, H., Sun, F., Xu, J., Wu, Z., et al. A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjögren's syndrome at 7q11.23. Nat Genet 45:11 (2013), 1361–1365.
162. Burbelo, P.D., Ambatipudi, K., Alevizos, I., Genome-wide association studies in Sjögren's syndrome: what do the genes tell us about disease pathogenesis?. Autoimmun Rev 13:7 (2014), 756–761.
163. Na, K.S., Mok, J.W., Kim, J.Y., Joo, C.K., Proinflammatory gene polymorphisms are potentially associated with Korean non-Sjogren dry eye patients. Mol Vis 17 (2011), 2818–2823.
164. Ren, G., Shao, T., Zhuang, Y., Hu, H., Zhang, X., Huang, J., et al. Association of killer cell immunoglobulin-like receptor and human leukocyte antigen-C genotype with dry eye disease in a Chinese Han population. Genet Test Mol Biomarkers 16:8 (2012), 910–914.
165. Ren, G., Li, H., Qiao, W., Shen, H., Zhuang, Y., Shao, T., et al. Possible association of killer cell immunoglobulin-like receptor genotypes and haplotypes with dry eye disease in a Han Chinese population. Mol Vis 21 (2015), 948–954.
166. Rodriguez-Rodriguez, L., Ramón Lamas, J., Abásolo, L., Baena, S., Olano-Martin, E., Collado, A., et al. The rs3771863 single nucleotide polymorphism of the TACR1 gene is associated to a lower risk of sicca syndrome in fibromyalgia patients. Clin Exp Rheumatol 33:1 Suppl 88 (2015 Jan-Feb), S33–S40.
167. Hallak, J.A., Tibrewal, S., Mohindra, N., Gao, X., Jain, S., Single nucleotide polymorphisms in the BDNF, VDR, and DNASE 1 genes in dry eye disease patients: a case-control study. Invest Ophthalmol Vis Sci 56:10 (2015), 5990–5996.
168. Bron, A.J., Yokoi, N., Gafney, E., Tiffany, J.M., Predicted phenotypes of dry eye: proposed consequences of its natural history. Ocul Surf 7:2 (2009), 78–92.
169. Lienert, J.P., Tarko, L., Uchino, M., Christen, W.G., Schaumberg, D.A., Long-term natural history of dry eye disease from the Patient's perspective. Ophthalmology 123:2 (2016), 425–433.
170. Wan, K.H., Chen, L.J., Young, A.L., Efficacy and safety of topical 0.05% cyclosporine eye drops in the treatment of dry eye syndrome: a systematic review and meta-analysis. Ocul Surf 13:3 (2015), 213–225.
171. Ansari, Z., Singh, R., Alabiad, C., Galor, A., Prevalence, risk factors, and morbidity of eye lid laxity in a veteran population. Cornea 34:1 (2015), 32–36.
172. Lin, P.Y., Cheng, C.Y., Hsu, W.M., Tsai, S.Y., Lin, M.W., Liu, J.H., et al. Association between symptoms and signs of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study. Invest Ophthalmol Vis Sci 46:5 (2005), 1593–1598.
173. Viso, E., Rodríguez-Ares, M.T., Bóveda, F.J., Touriño, R., Gude, F., Prevalence of conjunctival shrinkage and its association with dry eye disease: results from a population-based study in Spain. Cornea 33:5 (2014), 442–447.
174. Brown, M.M., Brown, G.C., Brown, H.C., Peet, J., Roth, Z., Value-based medicine, comparative effectiveness, and cost-effectiveness analysis of topical cyclosporine for the treatment of dry eye syndrome. Arch Ophthalmol 127:2 (2009), 146–152.
175. Clegg, J.P., Guest, J.F., Lehman, A., Smith, A.F., The annual cost of dry eye syndrome in France, Germany, Italy, Spain, Sweden and the United Kingdom among patients managed by ophthalmologists. Ophthalmic Epidemiol 13:4 (2006), 263–274.
176. Galor, A., Zheng, D.D., Arheart, K.L., Lam, B.L., Perez, V.L., McCollister, K.E., et al. Dry eye medication use and expenditures: data from the medical expenditure panel survey 2001 to 2006. Cornea 31:12 (2012), 1403–1407.
177. Mizuno, Y., Yamada, M., Shigeyasu, C., Annual direct cost of dry eye in Japan. Clin Ophthalmol 6 (2012), 755–760.
178. Patel, V.D., Watanabe, J.H., Strauss, J.A., Dubey, A.T., Work productivity loss in patients with dry eye disease: an online survey. Curr Med Res Opin 27:5 (2011), 1041–1048.
179. Uchino, M., Uchino, Y., Dogru, M., Kawashima, M., Yokoi, N., Komuro, A., et al. Dry eye disease and work productivity loss in visual display users: the Osaka study. Am J Ophthalmol 157:2 (2014), 294–300.
180. Waduthantri, S., Yong, S.S., Tan, C.H., Shen, L., Lee, M.X., Nagarajan, S., et al. Cost of dry eye treatment in an Asian clinic setting. PLoS One, 7, 2012, e37711.
181. Yamada, M., Mizuno, Y., Shigeyasu, C., Impact of dry eye on work productivity. Clinicoecon Outcomes Res 4 (2012), 307–312.
182. Yu, J., Asche, C.V., Fairchild, C.J., The economic burden of dry eye disease in the United States: a decision tree analysis. Cornea 30:4 (2011), 379–387.
183. Fiscella, R.G., Lee, J.T., Walt, J.G., Killian, T.D., Utilization characteristics of topical cycolsporine and punctal plugs in a managed care database. Am J Manag Care 14:3 Suppl (2008), S107–S112.
184. Wlodarczyk, J., Fairchild, C., United States cost-effectiveness study of two dry eye ophthalmic lubricants. Ophthalmic Epidemiol 16:1 (2009 Jan-Feb), 22–30.
185. Abetz, L., Rajagopalan, K., Mertzanis, P., Begley, C., Barnes, R., Chalmers, R., Impact of Dry Eye on Everyday Life (IDEEL) Study Group. Development and validation of the impact of dry eye on everyday life (IDEEL) questionnaire, a patient-reported outcomes (PRO) measure for the assessment of the burden of dry eye on patients. Health Qual Life Outcomes, 9, 2011, 111.
186. Uchino, M., Schaumberg, D.A., Dry eye disease: impact on quality of life and vision. Curr Ophthalmol Rep 1:2 (2013), 51–57.
187. McDonald, M., Patel, D.A., Keith, M.S., Snedecor, S.J., Economic and humanistic burden of dry eye disease in Europe, north America, and Asia: a systematic literature review. Ocul Surf 14 (2016), 144–167.
188. Mertzanis, P., Abetz, L., Rajagopalan, K., Espindle, D., Chalmers, R., Snyder, C., et al. The relative burden of dry eye in patients’ lives: comparisons to a U.S. normative sample. Invest Ophthalmol Vis Sci 46:1 (2005), 46–50.
189. Rajagopalan, K., Abetz, L., Mertzanis, P., Espindle, D., Begley, C., Chalmers, R., et al. Comparing the discriminative validity of two generic and one disease-specific health-related quality of life measures in a sample of patients with dry eye. Value health 8:2 (2005 Mar-Apr), 168–174.
190. Hackett, K.L., Newton, J.L., Frith, J., Elliott, C., Lendrem, D., Foggo, H., et al. Impaired functional status in primary Sjögren's syndrome. Arthritis Care Res (Hoboken) 64:11 (2012), 1760–1764.
191. Buchholz, P., Steeds, C.S., Stern, L.S., Wiederkehr, D.P., Doyle, J.J., Katz, L.M., et al. Utility assessment to measure the impact of dry eye disease. Ocul Surf 4:3 (2006), 155–161.
192. Belenguer, R., Ramos-Casals, M., Brito-Zerón, P., del Pino, J., Sentís, J., Aguiló S., et al. Influence of clinical and immunological parameters on the health-related quality of life of patients with primary Sjögren's syndrome. Clin Exp Rheumatol 23:3 (2005 May-Jun), 351–356.
193. Mizuno, Y., Yamada, M., Miyake, Y., Dry Eye Survey Group of the National Hospital Organization of Japan. Association between clinical diagnostic tests and health-related quality of life surveys in patients with dry eye syndrome. Jpn J Ophthalmol 54:4 (2010), 259–265.
194. Ware, J.E. Jr., Sherbourne, C.D., The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:6 (1992), 473–483.
195. Mangione, C.M., Lee, P.P., Gutierrez, P.R., Spritzer, K., Berry, S., Hays, R.D., National Eye Institute Visual Function Questionnaire Field Test Investigators. Development of the 25-item national eye Institute visual function questionnaire. Arch Ophthalmol 119:7 (2001), 1050–1058.
196. Vitale, S., Goodman, L.A., Reed, G.F., Smith, J.A., Comparison of the NEI-VFQ and OSDI questionnaires in patients with Sjögren's syndrome-related dry eye. Health Qual Life Outcomes, 2, 2004, 44.
197. Champey, J., Corruble, E., Gottenberg, J.E., Buhl, C., Meyer, T., Caudmont, C., et al. Quality of life and psychological status in patients with primary Sjögren's syndrome and sicca symptoms without autoimmune features. Arthritis Rheum 55:3 (2006), 451–457.
198. Fairchild, C.J., Chalmers, R.L., Begley, C.G., Clinically important difference in dry eye: change in IDEEL-symptom bother. Optom Vis Sci 85:8 (2008), 699–707.
199. Friedman, N.J., Impact of dry eye disease and treatment on quality of life. Curr Opin Ophthalmol 21:4 (2010), 310–316.
200. Miljanovic, B., Dana, R., Sullivan, D.A., Schaumberg, D.A., Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol 143 (2007), 409–415.
201. Denoyer, A., Rabut, G., Baudouin, C., Tear film aberration dynamics and vision-related quality of life in patients with dry eye disease. Ophthalmology 119:9 (2012), 1811–1818.
202. Koh, S., Maeda, N., Hirohara, Y., Mihashi, T., Ninomiya, S., Bessho, K., et al. Serial measurements of higher-order aberrations after blinking in normal subjects. Invest Ophthalmol Vis Sci 47:8 (2006), 3318–3324.
203. Li, M., Gong, L., Chapin, W.J., Zhu, M., Assessment of vision-related quality of life in dry eye patients. Invest Ophthalmol Vis Sci 53:9 (2012), 5722–5727.
204. Deschamps, N., Ricaud, X., Rabut, G., Labbé A., Baudouin, C., Denoyer, A., The impact of dry eye disease on visual performance while driving. Am J Ophthalmol 156:1 (2013), 184–189 e3.
205. Saboo, U.S., Amparo, F., Abud, T.B., Schaumberg, D.A., Dana, R., Vision-related quality of life in patients with ocular graft-versus-host disease. Ophthalmology 122:8 (2015), 1669–1674.
206. Mandl, T., Hammar, O., Theander, E., Wollmer, P., Ohlsson, B., Autonomic nervous dysfunction development in patients with primary Sjogren's syndrome: a follow-up study. Rheumatology (Oxford) 49:6 (2010), 1101–1106.
207. Ng, W.F., Bowman, S.J., Primary Sjogren's syndrome: too dry and too tired. Rheumatology (Oxford) 49:5 (2010), 844–853.
208. Iannuccelli, C., Spinelli, F.R., Guzzo, M.P., Priori, R., Conti, F., Ceccarelli, F., et al. Fatigue and widespread pain in systemic lupus erythematosus and Sjögren's syndrome: symptoms of the inflammatory disease or associated fibromyalgia?. Clin Exp Rheumatol 30:6 Suppl 74 (2012 Nov-Dec), 117–121.
209. Hallak, J.A., Tibrewal, S., Jain, S., Depressive symptoms in patients with dry eye disease: a case-control study using the beck depression inventory. Cornea 34:12 (2015), 1545–1550.
210. Li, M., Gong, L., Sun, X., Chapin, W.J., Anxiety and depression in patients with dry eye syndrome. Curr Eye Res 36:1 (2011), 1–7.
211. Liyue, H., Chiang, P.P., Sung, S.C., Tong, L., Dry Eye-related visual blurring and irritative symptoms and their association with depression and anxiety in eye clinic patients. Curr Eye Res 41 (2016), 590–599.
212. Le, Q., Ge, L., Li, M., Wu, L., Xu, J., Hong, J., et al. Comparison on the vision-related quality of life between outpatients and general population with dry eye syndrome. Acta Ophthalmol 92:2 (2014), e124–e132.
213. Le, Q., Zhou, X., Ge, L., Wu, L., Hong, J., Xu, J., Impact of dry eye syndrome on vision-related quality of life in a non-clinic-based general population. BMC Ophthalmol, 12, 2012, 22.
214. Schaumberg, D.A., Gulati, A., Mathers, W.D., Clinch, T., Lemp, M.A., Nelson, J.D., et al. Development and validation of a short global dry eye symptom index. Ocul Surf 5:1 (2007), 50–57.
215. Amparo, F., Schaumberg, D.A., Dana, R., Comparison of two questionnaires for dry eye symptom assessment: the ocular surface disease index and the symptom assessment in dry eye. Ophthalmology 122:7 (2015), 1498–1503.
216. Sakane, Y., Yamaguchi, M., Yokoi, N., Uchino, M., Dogru, M., Oishi, T., et al. Development and validation of the dry eye-related quality-of-life score questionnaire. JAMA Ophthalmol 131:10 (2013), 1331–1338.
217. Sullivan, B.D., Crews, L.A., Messmer, E.M., Foulks, G.N., Nichols, K.K., Baenninger, P., et al. Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications. Acta Ophthalmol 92 (2014), 161–166.
218. Nichols, K.K., Nichols, J.J., Mitchell, G.L., The lack of association between signs and symptoms in patients with dry eye disease. Cornea 23:8 (2004), 762–770.
219. Schiffman, R.M., Christianson, M.D., Jacobsen, G., Hirsch, J.D., Reis, B.L., Reliability and validity of the ocular surface disease index. Arch Ophthalmol 118:5 (2000), 615–621.
220. Mangione, C.M., Lee, P.P., Pitts, J., Gutierrez, P., Berry, S., Hays, R.D., Psychometric properties of the national eye Institute visual function questionnaire (NEI-VFQ). NEI-VFQ field test investigators. Arch Ophthalmol 116:11 (1998), 1496–1504.
221. Posa, A., Sel, S., Dietz, R., Sander, R., Brauer, L., Paulsen, F., Updated incidence of dry eye syndrome in Germany. Klin Monbl Augenheilkd 231 (2014), 42–46.
222. Oden, N.L., Lilienfeld, D.E., Lemp, M.A., Nelson, J.D., Ederer, F., Sensitivity and specificity of a screening questionnaire for dry eye. Adv Exp Med Biol 438 (1998), 807–820.
223. McMonnies, C.W., Key questions in a dry eye history. J Am Optom Assoc 57:7 (1986), 512–517.
224. Nichols, J.J., Mitchell, G.L., Nichols, K.K., An assessment of self-reported disease classification in epidemiological studies of dry eye. Invest Ophthalmol Vis Sci 45:10 (2004), 3453–3457.
225. Begley, C.G., Chalmers, R.L., Abetz, L., Venkataraman, K., Mertzanis, P., Caffery, B.A., et al. The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity. Invest Ophthalmol Vis Sci 44:11 (2003), 4753–4761.
226. Grubbs, J. Jr., Huynh, K., Tolleson-Rinehart, S., Weaver, M.A., Williamson, J., Lefebvre, C., et al. Instrument development of the UNC dry eye management scale. Cornea 33:11 (2014), 1186–1192.
227. Simpson, T.L., Situ, P., Jones, L.W., Fonn, D., Dry eye symptoms assessed by four questionnaires. Optom Vis Sci 85:8 (2008), 692–699.
228. Asiedu, K., Kyei, S., Mensah, S.N., Ocansey, S., Abu, L.S., Kyere, E.A., Ocular surface disease index (OSDI) versus the standard patient evaluation of eye dryness (SPEED): a study of a nonclinical sample. Cornea 35:2 (2016), 175–180.
229. Doughty, M.J., Fonn, D., Richter, D., Simpson, T., Caffery, B., Gordon, K., A patient questionnaire approach to estimating the prevalence of dry eye symptoms in patients presenting to optometric practices across Canada. Optom Vis Sci 74 (1997), 624–631.
230. Bandeen-Roche, K., Muñoz, B., Tielsch, J.M., West, S.K., Schein, O.D., Self-reported assessment of dry eye in a population-based setting. Invest Ophthalmol Vis Sci 38:12 (1997), 2469–2475.
231. Bjerrum, K.B., Test and symptoms in keratoconjunctivitis sicca and their correlation. Acta Ophthalmol Scand 74:5 (1996), 436–441.
232. Shimmura, S., Shimazaki, J., Tsubota, K., Results of a population-based questionnaire on the symptoms and lifestyles associated with dry eye. Cornea 18:4 (1999), 408–411.
233. Gulati, A., Sullivan, R., Buring, J.E., Sullivan, D.A., Dana, R., Schaumberg, D.A., Validation and repeatability of a short questionnaire for dry eye syndrome. Am J Ophthalmol 142:1 (2006), 125–131.
234. Begley, C.G., Caffery, B., Chalmers, R.L., Mitchell, G.L., Dry Eye Investigation (DREI) Study Group. Use of the dry eye questionnaire to measure symptoms of ocular irritation in patients with aqueous tear deficient dry eye. Cornea 21:7 (2002), 664–670.
235. Chalmers, R.L., Begley, C.G., Caffery, B., Validation of the 5-Item Dry Eye Questionnaire (DEQ-5): discrimination across self-assessed severity and aqueous tear deficient dry eye diagnoses. Cont Lens Anterior Eye 33:2 (2010), 55–60.
236. Ngo, W., Situ, P., Keir, N., Korb, D., Blackie, C., Simpson, T., Psychometric properties and validation of the standard patient evaluation of eye dryness questionnaire. Cornea 32:9 (2013), 1204–1210.
237. Craig, J.P., Nichols, K.K., Akpek, E.K., Caffery, B., Dua, H.S., Joo, C.K., et al. TFOS DEWS II Definition and Classification report. Ocul Surf 15 (2017), 276–283.